Opioid addiction is surely an immense public wellbeing disaster. Addressing it has become the FDA’s best priorities and supports the U.S. Department of Health and Human Services’ 5-Issue Strategy To Overcome the Opioid Crisis. 1 crucial step to addressing this public wellbeing unexpected emergency would be the adoption of a more proactive appro